Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Modern Age vs OlleveCare

Modern Age
Graded #361

Higher grade

vs+12.5
OlleveCare
Graded #497

Lower grade

The verdict

Modern Age takes it — 58.7/100 to 46.2/100.

Modern Age grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Modern Age is a longevity-focused health clinic that uses FDA-approved branded GLP-1 medication (semaglutide - Wegovy/Ozempic) within a structured Weight Loss Program.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationModern Age +13
53
40
Clinical oversightModern Age +30
83
53
Labs & monitoringModern Age +28
77
49
FulfillmentModern Age +21
59
38
Contract termsOlleveCare +35
20
55
Modern Age · left barOlleveCare · right bar

The numbers

MetricModern AgeOlleveCare
WeighScore58.7/10046.2/100
GradeCC
Scorecard rank#361#497
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published13 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Modern Age

Graded #361 · C

Strengths

  • Uses FDA-approved branded GLP-1 medication (Wegovy/Ozempic), no compounding
  • Comprehensive assessment with labs, at-home tests and clinician review
  • Board-certified clinicians and structured 6-month program
  • Longevity-oriented, whole-person approach beyond weight loss

Where it loses points

  • Expensive: $500 assessment plus $500 program, with medication billed separately
  • Branded GLP-1 can cost $900-1600/mo if not covered by insurance
  • Only available in 16 states (specific states not listed publicly)
  • Premium positioning makes it costlier than compounded-subscription rivals
OlleveCare

Graded #497 · C

Strengths

  • 13 states listed explicitly (VA, FL, AZ, MA, HI, IA, MD, NM, WA, KS, NY, DC, ID)
  • Both semaglutide and tirzepatide offered — switch molecules without switching platforms
  • Multi-service platform — GLP-1, virtual urgent care, and non-controlled refills with one provider
  • Cash-pay with a superbill option for out-of-network reimbursement
  • Founder Ahmed Emam is named in the footer

Where it loses points

  • Legal entity name not disclosed anywhere — can't be verified in a state registry
  • Pricing not shown before booking — you must enter the intake flow to see the fee
  • Pharmacy partner not named; model appears to fill at your preferred retail pharmacy
  • No medical director or prescribing clinician named — only 'board-certified providers'
  • No LegitScript badge, BBB profile, or HIPAA/SOC 2 seals displayed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard